传出细胞增多
医学
慢性阻塞性肺病
肺泡巨噬细胞
重症监护医学
免疫学
恶化
疾病
巨噬细胞
病理
内科学
生物化学
化学
体外
作者
Xuening Liu,Shanshan Cui,Yulong Chen,Xiaoling Gao,Lu Liu
出处
期刊:Chinese critical care medicine
[Chinese Medical Association]
日期:2019-07-01
卷期号:31 (7): 913-915
标识
DOI:10.3760/cma.j.issn.2095-4352.2019.07.024
摘要
As one of the top three causes of death in the world, chronic obstructive pulmonary disease (COPD)is a serious hazard to human health. Macrophages play an important role in COPD, and their efferocytosis function is essential for ending chronic inflammation of COPD. Efferocytosis damage of alveolar macrophages (AM) in patients with COPD causes the rising of bacterial infection and airway bacterial colonization risk in lungs, which is the main reason for the acute exacerbation and the rising of incidence rate and mortality rate in COPD. In recent years, the regulation of macrophage efferocytosis function in COPD has becoming a research hotspot. Progress on the role of macrophage efferocytosis function on COPD, and the breakthrough points of improving AM efferocytosis dysfunction by traditional Chinese medicine is reviewed, so as to provide new ideas for the prevention and treatment of COPD.
Key words:
Chronic obstructive pulmonary disease; Alveolar macrophages; Efferocytosis
科研通智能强力驱动
Strongly Powered by AbleSci AI